Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3885588 Target Snapshot

Histone acetyltransferase p300/Hypoxia-inducible factor 1-alpha · PROTEIN COMPLEX · Homo sapiens

17Compounds
14Assays
0Approved Drugs
17.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q09472. Use UniProt Q09472 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q09472 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Histone acetyltransferase p300/Hypoxia-inducible factor 1-alpha as ChEMBL target CHEMBL3885588, mapped to UniProt Q09472. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Histone acetyltransferase p300/Hypoxia-inducible factor 1-alpha
PROTEIN COMPLEX · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3885588
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q09472
Histone acetyltransferase p300
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Histone acetyltransferase p300/Hypoxia-inducible factor 1-alpha is the right protein anchor across sources, using UniProt Q09472 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHistone acetyltransferase p300
UniProt AccessionQ09472
Component TypeProtein
Sequence Length2414 aa

Histone acetyltransferase p300

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Histone acetyltransferase p300/Hypoxia-inducible factor 1-alpha, mapped to UniProt Q09472. ChEMBL maps the protein component as Histone acetyltransferase p300. Sequence length is 2414 aa.

Mapped IDQ09472
Review nameHistone acetyltransferase p300/Hypoxia-inducible factor 1-alpha
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC5016.0
KI1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1940227 6.55 IC50 280.0 Preclinical
CHEMBL499593 6.27 IC50 540.0 Preclinical
CHEMBL1823895 6.23 IC50 590.0 Preclinical
CHEMBL4542925 6.22 IC50 600.0 Preclinical
CHEMBL4574165 6.05 IC50 900.0 Preclinical
CHEMBL4080730 6.0 IC50 1000.0 Preclinical
CHEMBL4555191 5.82 IC50 1500.0 Preclinical
CHEMBL4524475 5.46 Ki 3500.0 Preclinical
CHEMBL5272424 5.04 IC50 9200.0 Preclinical
CHEMBL1089316 4.9 IC50 12500.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
1
5.5
5
6.0
1
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

14
Total Assays
15
Tested Compounds
1
Assay Types
Binding — 14 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
protein complex format 12 14 5.2
cell-based format 2 1 6.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine